Interleukin-2 (IL-2) as a consolidative treatment after autologous bone marrow transplantation for hematologic malignancies.

被引：0
|
作者：
Massumoto, C [1 ]
Ostronoff, M [1 ]
Macedo, MCMA [1 ]
ZAmbon, E [1 ]
Medeiros, RSS [1 ]
DorlhiacLlacer, PE [1 ]
Chamone, DAF [1 ]
Dulley, F [1 ]
机构：
[1] UNIV SAO PAULO,HEMOCTR SAO PAULO,FDN PRO SANGUE,BR-05508 SAO PAULO,BRAZIL
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3817 / 3817
页数：1
相关论文
共 50 条
  • [1] INTERLEUKIN-2 THERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
    FEFER, A
    BENYUNES, MC
    MASSUMOTO, C
    HIGUCHI, C
    YORK, A
    BUCKNER, CD
    THOMPSON, JA
    SEMINARS IN ONCOLOGY, 1993, 20 (06) : 41 - 45
  • [2] INTERLEUKIN-2+/-LYMPHOCYTES AS CONSOLIDATIVE IMMUNOTHERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
    FEFER, A
    BENYUNES, M
    HIGUCHI, C
    YORK, A
    MASSUMOTO, C
    LINDGREN, C
    BUCKNER, CD
    THOMPSON, JA
    ACTA HAEMATOLOGICA, 1993, 89 : 2 - 7
  • [3] Immunotherapy of hematologic malignancies with autologous bone marrow transplant (ABMT) using in vitro interleukin-2 (IL-2)-treated bone marrow (BM).
    Margolin, K
    vanBesien, K
    Wright, C
    Woo, D
    Champlin, R
    Thomas, M
    Davis, M
    Grimm, E
    Forman, S
    BLOOD, 1995, 86 (10) : 1541 - 1541
  • [4] LYMPHOCYTES-IL2+/- AS CONSOLIDATIVE IMMUNOTHERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR HEMATOLOGIC MALIGNANCIES
    FEFER, A
    BENYUNES, M
    HIGUCHI, C
    YORK, A
    MASSUMOTO, C
    LINDGREN, C
    BUCKNER, CD
    THOMPSON, JA
    BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (01) : 285 - 286
  • [5] TOXICITY AND IMMUNOMODULATORY EFFECTS OF INTERLEUKIN-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
    HIGUCHI, CM
    THOMPSON, JA
    PETERSEN, FB
    BUCKNER, CD
    FEFER, A
    BLOOD, 1991, 77 (12) : 2561 - 2568
  • [6] CONSOLIDATIVE IMMUNOTHERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
    BENYUNES, M
    YORK, A
    LINDGREN, C
    HIGUCHI, C
    THOMPSON, JA
    BUCKNER, CD
    FEFER, A
    CLINICAL RESEARCH, 1992, 40 (02): : A171 - A171
  • [7] AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) WITH INTERLEUKIN-2 (IL-2) - ACTIVATED BONE-MARROW
    CHARAK, B
    VERMA, U
    CAHILL, R
    MAZUMDER, A
    BLOOD, 1993, 82 (10) : A628 - A628
  • [8] Interleukin-2 therapy after bone marrow or stem cell transplantation for hematologic malignancies
    Fefer, A
    Robinson, N
    Benyunes, MC
    Bensinger, WI
    Press, O
    Thompson, JA
    Lindgren, C
    CANCER JOURNAL, 1997, 3 : S48 - S53
  • [9] Interleukin-2 (IL-2) post high dose chemotherapy mobilized autologous stem cell transplant (ASCT) for hematologic malignancies.
    Oliveira, JSR
    Cecyn, KZ
    Parisio, K
    Faria, JR
    Ribeiro, MSS
    Chauffaille, MDLF
    Raineri, G
    BLOOD, 2001, 98 (11) : 396B - 397B
  • [10] PRODUCTION OF INTERLEUKIN-2 (IL-2) EARLY AFTER BONE-MARROW TRANSPLANTATION (BMT)
    SHERIDAN, JF
    DAVAKIS, LA
    CLOUSE, KA
    TUTSCHKA, PJ
    EXPERIMENTAL HEMATOLOGY, 1985, 13 (05) : 325 - 325
12345